abstract |
The present invention relates to tenofovir disoproxil succinate, tenofovir disoproxil L-tartrate, tenofovir disoproxil oxalate, tenofovir disoproxil saccharate, tenofovir disoproxil citrate, tenofovir disoproxil salicylate, and various The present invention relates to solids, their preparation methods and their use as pharmaceuticals, especially in anti-HIV agents. The form of tenofovir disoproxil can be used in combination with other anti-HIV agents such as efavirenz and emtricitabine. |